Doximity DOCS reported fourth-quarter fiscal 2025 adjusted earnings per share (EPS) of 38 cents, which beat the Zacks ...

For the full year, it wasn't much better. The consensus called for $635 million in revenue for the fiscal year ending in March 2026, and Doximity guided for $625 million at the midpoint. This would ...

Doximity saw increased retail buzz on Thursday following its fourth-quarter (Q4) earnings report, which displayed strong ...

Shares of the leading digital platform for U.S. medical professionals, Doximity (NYSE: DOCS), were down 14% as of noon ET ...

Shares of Doximity plummeted late Thursday after the telehealth software company dished out a disappointing outlook.

Doximity faces flat growth, competitive pressure, and overvaluation, making it a potential short with a $45 target. Click ...

Doximity's Q4 performance likely witnessed strong product ... holding steady at $58. However, the stock is beating the S&P 500’s 6.2% decline during that period. Doximity (DOCS) concluded ...

In light of the recent options history for Doximity, it's now appropriate to focus on the company itself. We aim to explore its current performance ... suggest the stock is currently may be ...

Despite these positive results, Doximity’s stock fell sharply in aftermarket trading, dropping 23.44% to $44.75. Doximity demonstrated robust financial performance in Q4 FY2025, with revenue growing ...

Doximity DOCS reported fourth-quarter fiscal ... shares of DOCS plunged 20.7% during after-hours trading on May 15. The stock fell 9.5% year to date compared with a 6.2% decline in the industry.

Doximity reported fourth-quarter fiscal 2025 ... shares of DOCS plunged 20.7% during after-hours trading on May 15. The stock fell 9.5% year to date compared with a 6.2% decline in the industry.